Skip to content

Released Mar 1, 2022, after the close

10-K filed Mar 1, 2022, 60 days after period end · 0001636422-22-000011

Q4 2021 · 10-K

derived · Computed from the longer spans the company filed.

Revenue$64.72Mderived+21.5% vs Q4 2020+4.8% vs Q3 2021
Net Income-$48.99MderivedN/M vs Q4 2020N/M vs Q3 2021
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$44,765,000N/M
Operating Cash Flowderived-$9,775,000N/M
Free Cash Flowderived-$10,398,000N/M
Margins · derived
Operating margin-69.2%+3.9 pt vs Q4 2020
Net margin-75.7%+5.0 pt vs Q4 2020

What the release said

The release

Same quarter

MetricQ4 2021derived from reported figuresQ4 2020derived from reported figuresQ4 2019derived from reported figuresQ4 2018derived from reported figures
Revenue$64.72M$53.28M$43.50M—
Net Income-$48.99M-$43.02M-$14.27M—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR